Circulatory insulin-like growth factor 1 predicts metastasis in triple-negative breast cancer

被引:0
|
作者
Akter, Salima [1 ]
Faruque, Mithila [2 ]
Akhter, Hajara [3 ]
Bhowmik, Mousumi [4 ]
Hasan, Mohammad Nazmul [2 ]
Sultana, Lipika [5 ]
Khan, Imran [6 ]
Mia, Mamun [7 ]
Rahman, Md Mustafizur [8 ]
Chaudhury, Habib Sadat [9 ]
Rafiqul, Islam S. [4 ]
Nahar, Kamrun [10 ]
Choi, Tae Gyu [1 ]
Kim, Sung Soo [1 ]
机构
[1] Kyung Hee Univ, Seoul, South Korea
[2] Bangladesh Univ Hlth, Dhaka, Bangladesh
[3] Bangladesh Council Sci & Ind Res, Biomed & Toxicol Res Inst, Dhaka, Bangladesh
[4] Univ Chittagong, Chittagong, Bangladesh
[5] Bangladesh Univ Hlth Sci, Dhaka, Bangladesh
[6] R&D Incepta Vaccine Ltd, Dhaka, Bangladesh
[7] AICHI Hosp Ltd, RT PCR Lab, Dhaka, Bangladesh
[8] Khulna Univ, Khulna, Bangladesh
[9] Int Med Coll Hosp, Tongi, Bangladesh
[10] Bangabandhu Sheikh Mujib Med Univ, Dhaka, Bangladesh
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1526
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Concentration of insulin-like growth factor is linked with breast cancer
    Wilkins, Rebecca
    BRITISH MEDICAL JOURNAL, 2010, 340
  • [42] Targeting insulin-like growth factor in breast cancer therapeutics
    Karamouzis, Michalis V.
    Papavassiliou, Athanasios G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 (01) : 8 - 17
  • [43] INSULIN-LIKE GROWTH FACTOR-I RECEPTORS AND INSULIN-LIKE GROWTH FACTOR-1-LIKE ACTIVITY IN HUMAN PRIMARY BREAST-CANCER
    FOEKENS, JA
    PORTENGEN, H
    JANSSEN, M
    KLIJN, JGM
    CANCER, 1989, 63 (11) : 2139 - 2147
  • [44] Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis
    Zhong, Ying
    Ren, Xinyu
    Cao, Xi
    Xu, Yali
    Song, Yu
    Zhou, Yidong
    Mao, Feng
    Shen, Songjie
    Wang, Zhe
    Sun, Qiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotheraphy
    Julovi, Sohel M.
    Martin, Janet L.
    Baxter, Robert C.
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [46] Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancer
    Li, H.
    Zhao, M.
    Wang, Q.
    Liu, L.
    Qi, Y. N.
    Li, J. Y.
    CURRENT ONCOLOGY, 2016, 23 (01) : E17 - E23
  • [47] Canine invasive mammary carcinoma as a spontaneous model for insulin-like growth factor-1 receptor-overexpressing triple negative breast cancer
    Jaillardon, L.
    Nguyen, F.
    Loussouarn, D.
    Godard, T.
    Abadie, J.
    Siliart, B.
    Campone, M.
    CANCER RESEARCH, 2013, 73
  • [48] MicroRNA-606 inhibits the growth and metastasis of triple-negative breast cancer by targeting Stanniocalcin 1
    Choi, Sujin
    An, Hyun-Ju
    Yeo, Hyun Jeong
    Sung, Min-Ji
    Oh, Jisu
    Lee, Kwanbum
    Lee, Seung Ah
    Kim, Seung Ki
    Kim, Junhan
    Kim, Isaac
    Lee, Soonchul
    ONCOLOGY REPORTS, 2024, 51 (01)
  • [49] The role of endothelial ACKR1 in triple-negative breast cancer metastasis
    Roach, Samuel Tanner
    Ewenighi-Amankwah, Chinwe
    Dufraine, J.
    Naiche, L. A.
    Kitajewski, Jan K.
    CANCER RESEARCH, 2023, 83 (07)
  • [50] Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer
    Acharya, Sunil
    Yao, Jun
    Li, Ping
    Zhang, Chenyu
    Lowery, Frank J.
    Zhang, Qingling
    Guo, Hua
    Qu, Jingkun
    Yang, Fei
    Wistuba, Ignacio I.
    Piwnica-Worms, Helen
    Sahin, Aysegul A.
    Yu, Dihua
    CANCER RESEARCH, 2019, 79 (16) : 4211 - 4226